1040 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
21 Not yet recruiting A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Conditions: Advanced Cancer;   Metastatic Melanoma;   Metastatic Non-small Cell Lung Cancer;   Metastatic Pancreatic Ductal Adenocarcinoma;   Colorectal Cancer
Interventions: Drug: LY3214996;   Drug: Midazolam;   Drug: Abemaciclib;   Drug: Nab-paclitaxel;   Drug: Gemcitabine
22 Not yet recruiting Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer
Condition: Lung Neoplasms
Intervention:
23 Not yet recruiting A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1
Condition: Advanced or Metastatic Non-small Cell Lung Cancer
Interventions: Drug: TAS-114;   Drug: S-1
24 Recruiting A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC
Conditions: Squamous Cell Lung Cancer;   Non-Squamous Cell Lung Cancer;   Non-Small Cell Lung Cancer
Interventions: Drug: Pioglitazone;   Drug: nivolumab;   Drug: Treosulfan;   Drug: Clarithromycin
25 Not yet recruiting Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Carcinoma
Intervention:
26 Not yet recruiting A Study of Atezolizumab (MPDL3280A) as First-line Monotherapy for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC): Clinical Evaluation of Novel Blood-Based Diagnostics [B-F1RST]
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Atezolizumab
27 Recruiting A Positron Emission Tomography (PET) Imaging Agent [18F]-ODS2004436 as a Marker of EGFR Mutation in Subjects With NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Other: Injection of [18F]-ODS2004436 radiotracer
28 Not yet recruiting Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer
Conditions: Recurrent Non-Small Cell Lung Carcinoma;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Drug: Plinabulin
29 Recruiting Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer
Condition: Recurrent Non-small Cell Lung Cancer
Interventions: Drug: Cetuximab;   Biological: NK immunotherapy
30 Not yet recruiting DE-CT in Lung Cancer Proton Therapy
Condition: Non Small Cell Lung Cancer
Intervention: Procedure: DE-CT's and SE-CT
31 Recruiting Clinical Study of Ganoderma Lucidum Spore Combined With Chemotherapy
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Ganoderma lucidum spore;   Drug: Placebo;   Drug: Chemotherapy
32 Recruiting Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer Metastatic
Interventions: Device: Cryosurgery;   Biological: NK Immunotherapy
33 Recruiting Improving Pulmonary Function Following Radiation Therapy
Condition: Non-Small Cell Lung Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Radiation: Standard fractionation;   Radiation: Stereotactic Body Radiation Therapy (SBRT);   Procedure: Four Dimensional Computed Tomographic Imaging (4DCT)
34 Not yet recruiting Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Osimertinib
35 Recruiting Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Radiation: IMRT + SIB + Chemotherapy
36 Not yet recruiting A Trial of CV301 in Combination With Nivolumab Versus Nivolumab in Subjects With Previously Treated Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer (NSCLC)
Interventions: Biological: CV301;   Biological: nivolumab
37 Recruiting The Effect of Combined General/Regional Anesthesia on Cancer Recurrence in Patients Having Lung Cancer Resections
Condition: Non-small Cell Lung Cancer
Interventions: Drug: General anesthesia;   Drug: Combined general/epidural anesthesia
38 Recruiting CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor
Conditions: Hepatocellular Carcinoma;   Non-small Cell Lung Cancer;   Pancreatic Carcinoma;   Triple-Negative Invasive Breast Carcinoma;   Malignant Glioma of Brain;   Colorectal Carcinoma;   Gastric Carcinoma
Intervention: Biological: anti-MUC1 CAR-pNK cells
39 Recruiting FLT3 Ligand Immunotherapy and Stereotactic Radiotherapy for Advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: FLT3 Ligand Therapy (CDX-301);   Radiation: Stereotactic Body Radiotherapy (SBRT)
40 Recruiting Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Conditions: Non-small Cell Lung Cancer;   Esophageal Cancer;   Gastric Cancer;   Pancreatic Cancer;   Hepatocellular Cancer;   Colorectal Cancer
Intervention: Other: Blood draws, urine and tissue asservation, bone marrow aspiration

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years